Olanzapine versus aprepitant for the prophylaxis of chemotherapy-induced nausea and vomiting in breast cancer patients receiving doxorubicin-cyclophosphamide regimen: a prospective, nonrandomized, open-label study - Shivaprakash, G; Udupa, K S; Sarayu, V (Indian J Pharmacol, 2017)